Patent Armory v. Merck KGaA: Five Routing Patents Dismissed Without Prejudice
Patent Armory, Inc. brought a five-patent infringement action against Merck KGaA in the Eastern District of Texas, asserting patents covering intelligent communication routing, auction-based entity matching, and telephony control systems. The case ended in voluntary dismissal without prejudice under Rule 41 after just 167 days — before Merck KGaA filed any answer.
Early voluntary exit: five routing patents dropped before answer
Patent Armory, Inc. filed Case No. 2:24-cv-00419 in the Eastern District of Texas on 5 June 2024 before Judge Rodney Gilstrap, one of the most active patent benches in the United States. The complaint asserted five U.S. patents — US9456086B1, US10491748B1, US7269253B1, US7023979B1, and US10237420B1 — covering intelligent communication routing systems, telephony control with intelligent call routing, and auction-based entity matching methods, against Merck KGaA, the German science and technology company.
On 19 November 2024, Patent Armory filed a Notice of Voluntary Dismissal Without Prejudice pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i). Because Merck KGaA had not yet answered the complaint or moved for summary judgment, Patent Armory was entitled to dismiss as of right — no court order or defendant consent was required. Judge Gilstrap accepted and acknowledged the dismissal, closed the case, and directed each party to bear its own costs and attorneys’ fees.
The 167-day lifespan and pre-answer exit suggest the parties may have reached an informal resolution, or that Patent Armory reassessed the litigation posture before incurring discovery costs. The public record does not disclose any licensing agreement or settlement terms. Dismissal without prejudice means the same patents could theoretically be asserted again against Merck KGaA or other defendants, though refiling in E.D. Texas against the same party would face strategic scrutiny.
Filing to Dismissed without Prejudice in 167 days
167 days — resolved before defendant’s answer was filed
Dismissed without prejudice: what the Rule 41 exit means for both parties
Rule 41(a)(1)(A)(i): dismissal as of right, no court order needed
Under FRCP 41(a)(1)(A)(i), a plaintiff may dismiss without court approval at any time before the defendant serves an answer or a motion for summary judgment. Because Merck KGaA had not yet answered, Patent Armory exercised this right unilaterally. The court’s order simply accepts and acknowledges the dismissal — it carries no merits ruling on infringement or validity.
No merits adjudicatedClaims survive: the door remains open for refiling
A dismissal without prejudice does not extinguish the underlying claims. Patent Armory retains the right to assert the same five patents — US9456086B1, US10491748B1, US7269253B1, US7023979B1, and US10237420B1 — in a future action, subject to any applicable statute of limitations. No judgment on infringement, validity, or enforceability was entered. Merck KGaA obtained no declaratory judgment of non-infringement.
Claims not extinguishedMerck KGaA exits without prejudice — no clean IP clearance
While Merck KGaA avoids immediate litigation cost and the risk of an infringement finding, the dismissal without prejudice provides no formal IP clearance. The company cannot rely on res judicata or claim preclusion to bar future suits on these patents. A proactive freedom-to-operate analysis or inter partes review of the asserted patents may be warranted if Merck KGaA’s relevant product lines remain unchanged.
No preclusion obtainedFive routing patents remain live — sector-wide exposure persists
Patent Armory’s portfolio of intelligent communication routing and telephony patents remains intact and unlitigated on the merits. Companies operating routing platforms, call-centre infrastructure, or auction-based matching systems should treat these patents as active enforcement risks. The pre-answer dismissal pattern is consistent with assertion strategies that test defendant responses before committing to full litigation.
Continued assertion riskFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Patent Armory, Inc. | Company | Patent assertion entity — holder of US9456086B1 and four related routing patentsSearch in Eureka ↗ |
| Defendant | Merk KGAA | Individual | Merck KGaA — German multinational science and technology companySearch in Eureka ↗ |
| Plaintiff counsel | Benjamin Charles Deming | Attorney | Counsel for Patent Armory, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Isaac Phillip Rabicoff | Attorney | Counsel for Patent Armory, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Dnl Zito | Law Firm | Representing Patent Armory, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Rabicoff Law LLC | Law Firm | Representing Patent Armory, Inc.Search in Eureka ↗ |
| Defendant counsel | Matthew J. Moffa | Attorney | Counsel for Merk KGAASearch in Eureka ↗ |
| Defendant counsel | Melissa Richards Smith | Attorney | Counsel for Merk KGAASearch in Eureka ↗ |
| Defendant counsel | Thatcher Albert Rahmeier | Attorney | Counsel for Merk KGAASearch in Eureka ↗ |
| Defendant counsel | William J. McCabe | Attorney | Counsel for Merk KGAASearch in Eureka ↗ |
| Defendant law firm | Drinker Biddle & Reath, LLP (Wilmington) | Law Firm | Representing Merk KGAASearch in Eureka ↗ |
| Defendant law firm | Gillam & Smith, LLP | Law Firm | Representing Merk KGAASearch in Eureka ↗ |
| Defendant law firm | Perkins Coie LLP | Law Firm | Representing Merk KGAASearch in Eureka ↗ |
| Defendant law firm | Perkins Coie LLP (NY) | Law Firm | Representing Merk KGAASearch in Eureka ↗ |
| Presiding judge | Judge Rodney Gilstrap | Judge | Texas Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The court’s order does not adjudicate infringement or patent validity — it solely accepts Patent Armory’s Rule 41(a)(1)(A)(i) notice of voluntary dismissal. The phrasing ‘ACCEPTS AND ACKNOWLEDGES’ is ministerial, not substantive. The direction that each party bear its own costs is standard for pre-answer voluntary dismissals. Merck KGaA emerges without a merits win, and Patent Armory retains all claims for potential future assertion.
US9456086B1 — Intelligent Communication Routing System
US9456086B1 (application US12/719827) is one of five patents asserted in this action, all centred on intelligent communication routing, telephony control, and auction-based entity matching. The portfolio spans priority filings from the mid-2000s to 2017, covering systems that intelligently route voice and data communications and match communication parties using algorithmic or auction-based logic. These foundational routing architectures underpin modern contact-centre, VoIP, and platform-communication technologies.
The breadth of the five-patent portfolio — spanning routing logic, telephony control, and entity-matching methods — creates potentially wide claim coverage across cloud communication platforms, contact-centre-as-a-service providers, and UCaaS vendors. The fact that Patent Armory chose Merck KGaA, a science and technology company, as a defendant suggests the asserted products may relate to enterprise communication infrastructure rather than consumer-facing telecom services, a distinction relevant to freedom-to-operate assessments.
Should you run an FTO against US9456086B1 and the Patent Armory routing portfolio?
Any company operating intelligent call routing, contact-centre platforms, telephony control systems, or auction-based matching in its communication stack should treat this five-patent portfolio as a live risk. The voluntary dismissal without prejudice means no invalidity or non-infringement determination was secured — Patent Armory can refile or assert the same patents against different defendants without restriction.
PatSnap Eureka’s FTO Search Agent can map the claim language of US9456086B1, US10491748B1, US7269253B1, US7023979B1, and US10237420B1 against your product architecture, identify potential design-arounds, and flag prior art relevant to IPR petitions. Running a structured FTO now — before any demand letter arrives — is significantly more cost-effective than responding to litigation in E.D. Texas.
Run a freedom-to-operate analysis on US9456086B1 to assess your product’s exposure
Run FTO in Eureka →Similar patent cases: communication routing litigation in E.D. Texas
Browse related infringement actions involving intelligent communication routing and telephony patents filed in the Eastern District of Texas before Judge Gilstrap.
What this case signals for the communication routing IP landscape
A rapid pre-answer withdrawal by a patent assertion entity in E.D. Texas rarely signals the end of the story.
Pre-answer dismissals in E.D. Texas often precede licensing discussions
When a plaintiff in the Eastern District of Texas voluntarily dismisses before the defendant answers, it typically suggests one of three scenarios: an informal licensing agreement, a strategic reassessment of claim strength, or a pivot to a different defendant. None can be confirmed here, but companies in the communication routing sector should monitor Patent Armory’s subsequent filing activity.
Five patents, no merits ruling — validity remains untested
Because the case closed without substantive proceedings, the validity and claim scope of all five asserted patents — including US9456086B1 and US10237420B1 — remain judicially untested. Any company operating intelligent routing or telephony infrastructure that overlaps with these claims faces residual risk until the patents expire or are challenged via IPR at the USPTO.
Patent v Merk — key questions answered
Patent Armory, Inc. filed a patent infringement action against Merck KGaA in the Eastern District of Texas on 5 June 2024, asserting five patents covering intelligent communication routing and telephony systems. On 19 November 2024, Patent Armory voluntarily dismissed the case without prejudice under FRCP 41(a)(1)(A)(i) before Merck KGaA filed an answer. Each party was directed to bear its own costs.
Dismissal without prejudice means no merits ruling was entered on infringement or patent validity. Merck KGaA obtained no judgment of non-infringement and cannot invoke res judicata to bar a future lawsuit on the same patents. The five asserted patents remain valid and enforceable, and Patent Armory retains the right to refile claims subject to applicable limitations periods.
Patent Armory asserted five U.S. patents: US9456086B1, US10491748B1, US7269253B1, US7023979B1, and US10237420B1. The patents cover intelligent communication routing systems, telephony control with intelligent call routing, and methods for matching entities in an auction — technologies relevant to enterprise communication infrastructure and contact-centre platforms.
The public record does not disclose the reason for the pre-answer dismissal. Common explanations in E.D. Texas patent litigation include an informal licensing arrangement, a strategic reassessment of claim strength, resource prioritisation across a broader assertion campaign, or a decision to pursue alternative defendants. The dismissal was filed as of right under FRCP 41(a)(1)(A)(i), requiring no court approval or defendant consent.
Yes. A Rule 41(a)(1)(A)(i) dismissal without prejudice does not extinguish the underlying patent claims. Patent Armory may refile against Merck KGaA or assert the same five patents against other defendants, subject to the six-year damages limitation period under 35 U.S.C. § 286 and any equitable defences. Potential defendants should consider inter partes review petitions to challenge patent validity proactively.
PatSnap Eureka searches patents and litigation data to answer instantly.